The Department of Health Bureau of Health Services Financing will be holding a public hearing on Thursday, February 28 on proposed rules amending the Pharmacy Benefits Management Program changing the pharmacy ingredient cost reimbursement methodology from average acquisition cost (AAC) to the national average drug acquisition cost (NADAC).
Also in Louisiana…The Board of Pharmacy finalized regulations that took effect on January 20 modifying the prescription monitoring program regulations to include naloxone as a drug of concern, thus requiring reporting and tracking for public health purposes.
For more information, contact NACDS’ Mary Staples at 817-442-1155.